A Curious Case of Gastrointestinal Eosinophilia Induced by Treatment With Immune Checkpoint Inhibitors

Immune checkpoint inhibitors have revolutionized oncologic treatment. However, they are linked to various side effects, a rare one being gastrointestinal eosinophilia. We present a patient with malignant melanoma treated with nivolumab. She underwent upper endoscopy 6 months later which showed a duo...

Full description

Saved in:
Bibliographic Details
Published in:ACG case reports journal 2023-06, Vol.10 (6), p.e01075-e01075
Main Authors: Reddy, Yala Kirthi, Fischer, Inderbitzin Sonya, Kolodney, Joanna, Willard, Megan
Format: Article
Language:English
Subjects:
Case Report
Esophagus
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Immune checkpoint inhibitors have revolutionized oncologic treatment. However, they are linked to various side effects, a rare one being gastrointestinal eosinophilia. We present a patient with malignant melanoma treated with nivolumab. She underwent upper endoscopy 6 months later which showed a duodenal ulcer and linear furrows of her esophagus. Biopsies of the esophagus, stomach, and duodenum were consistent with eosinophilic infiltration. Repeat endoscopy after nivolumab discontinuation revealed near-complete resolution of eosinophilia in the stomach and duodenum, with lingering eosinophilia in the esophagus. The purpose of this report was to increase awareness of gastrointestinal eosinophilia associated with checkpoint inhibitors.
ISSN:2326-3253
2326-3253
DOI:10.14309/crj.0000000000001075